Boris Grinshpun, Nels Thorsteinson, Joao NS Pereira, Friedrich Rippmann, David Nannemann, Vanita D. Sood, & Yves Fomekong Nanfack. (2021). Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies. Taylor & Francis Group.
Чикаго стиль цитування (17-те видання)Boris Grinshpun, Nels Thorsteinson, Joao NS Pereira, Friedrich Rippmann, David Nannemann, Vanita D. Sood, та Yves Fomekong Nanfack. Identifying Biophysical Assays and in Silico Properties That Enrich for Slow Clearance in Clinical-stage Therapeutic Antibodies. Taylor & Francis Group, 2021.
Стиль цитування MLA (9-ме видання)Boris Grinshpun, et al. Identifying Biophysical Assays and in Silico Properties That Enrich for Slow Clearance in Clinical-stage Therapeutic Antibodies. Taylor & Francis Group, 2021.